Searched for
KRISHNA M ELLA BHARAT BIOTECH
Covaxin for kids: Bharat Biotech completes phase 2/3 trials of vaccine, to submit data to DCGI next week21 Sep, 2021, 03.04 PM IST- COVID-19: Bharat Biotech's nasal vaccine phase III trials completed, informs Dr Krishna Ella19 Jun, 2022, 11.32 AM IST
- COVID vaccine approval row: Bharat Biotech defends Covaxin after backlash over lack of data04 Jan, 2021, 06.51 PM IST
- Momentous occasion for Indian science: Bharat Biotech MD after WHO grants EUL to Covaxin03 Nov, 2021, 11.07 PM IST
- Booster dose giving encouraging results against Omicron, data to be made public soon: Dr Krishna Ella, Bharat Biotech CMD12 Jan, 2022, 11.26 AM IST
- Covaxin for kids: SEC approves Bharat Biotech's COVID vaccine for children from 2 to 18 yrs12 Oct, 2021, 01.50 PM IST
- Immunocompromised people advised not to take Covaxin: Bharat Biotech releases detailed factsheet19 Jan, 2021, 11.03 AM IST
- Two PSUs enter into pact with Covaxin maker Bharat Biotech to produce Covid-19 vaccines13 May, 2021, 07.07 PM IST
- 'Only Covaxin to be administered to 15-18 age group': Bharat Biotech asks health workers to be 'vigilant'08 Jan, 2022, 10.40 AM IST
- COVID-19 vaccine: India aims to release indigenous 'Covaxin' by August 15, 2020; ICMR ramps up efforts03 Jul, 2020, 01.25 PM IST
- Bharat Biotech announces interim analysis results of Phase3 trials21 Apr, 2021, 04.06 PM IST
- Covaxin safe, well-tolerated in 2-18 years age-group: Bharat Biotech17 Jun, 2022, 12.15 PM IST
- Covaxin phase 3 trial data approved by subject expert committee, shows 77.8 % efficacy22 Jun, 2021, 03.30 PM IST
- Krishna Bharat: The man behind Google Newskb_2.jpg11 Sep, 2010, 02.00 PM IST
- COVID-19 vaccine: Australia recognises Bharat Biotech's Covaxin for travel purposes01 Nov, 2021, 12.27 PM IST
- Bharat Biotech's Nasal Vaccine available as booster dose on CoWIN App starting today23 Dec, 2022, 05.34 PM IST
- In conversation with Krishna Bharat, Principal Scientist, Googlekb.jpg11 Sep, 2010, 01.56 PM IST
- Covaxin likely to be available in first quarter of 2021: Bharat Biotech10 Dec, 2020, 08.21 AM IST
- India's Covaxin yet to receive WHO endorsement, govt to push for approval23 May, 2021, 10.19 AM IST
- After Covishield, Covaxin price slashed, Bharat Biotech to sell vaccine to state governments at Rs 400 per dose29 Apr, 2021, 06.29 PM IST
Load More
